Thursday, November 21, 2024 11/21/2024

The application is to advance ending hepatitis epidemics by active surveillance, collaborations with clinical and community-based partners through testing, treatment, and focus populations.

Award Number: NU51PS005139
ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES
OPDIV: CDC
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES

Group Awards By:

View Award Abstract

The District of Columbia continues to experience a severe epidemic of viral hepatitis with significant impact on the health and well-being of its residents. Between 2015 and 2019, 1,750 new cases of chronic hepatitis B (HBV) were reported. In 2019, the crude rate of chronic HBV was 42.9 cases per 100,000 population. With 98% of the cases among adults over the age of 20 years old, these cases were preventable by vaccine. Between 2015 and 2019, 15,811 cases of chronic hepatitis C (HCV) were reported, of which 6,671 (42.2%) represented new diagnoses. The crude rate of newly diagnosed chronic HCV within the District in 2019 was 156.5 cases per 100,000. While a slight increase has been observed in recent years, the rate of hepatitis A in the District of Columbia based on data reported to the Centers for Disease Control and Prevention (CDC) remains relatively low (1.6 cases per 100,000 population). The District maintained a high rate of hepatitis related deaths compared to the nation, significant of potential missed opportunities for preventing the adverse long-term sequelae associated with untreated infection. The purpose of this application is to advance an end of the hepatitis epidemics in the District of Columbia through active surveillance, collaborations with clinical and community-based partners on testing and treatment, and innovative strategies to engage focus populations. Overall, the project will leverage epidemiological data to increase testing, accelerate linkage to care, and enhance treatment options for hepatitis and substance use disorder. In five years, the District expects to achieve measurable progress to ending the hepatitis epidemics. Under surveillance, the District will increase reporting and completeness of data for adult and perinatal HBV and HCV, develop an outbreak response plan for applicable hepatitis viruses, and systematically monitor trends to inform program interventions. Under prevention, the District will increase testing (including automatic reflex testing), treatment prescribing and completion, and focus activities for people who use drugs, including use of SSPs, substance use treatment, vaccination, and integrated services. To achieve these outcomes, the District will engage community stakeholders, develop a hepatitis elimination plan, and address emerging conditions with flexibility and responsiveness. The DC Department of Health (DC Health) will leverage its existing working partnerships across government, jurisdictions, academic/research, community providers, education, and consumer and stakeholder groups. DC Health maintains partnerships with an extensive network of culturally diverse community providers, including hospitals, medical practices, federally quality health centers (FQHCs), and non-clinical community-based organizations, including syringe service and substance use treatment providers. DC Health has strong connections with people who use drugs through its robust peer network programs. It has current and prospective highly expert, dedicated, and innovative team members. DC commits to a robust evaluation, specific metrics, and continuous quality improvement to ensure effective results and operations. HAHSTA will utilize its capacity building resources for community partners and staff. The District has the foundational framework, robust collaborative partnerships, and willingness to promote innovative approaches to strengthen its surveillance, prevention, and program approaches for populations with the highest risk behavior for HBV and HCV. The District is committed to develop a plan leveraging the critical tools of testing, linkage to care, vaccination, and treatment to achieve an end to the hepatitis epidemics.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $315,000 )
2024	2024	DISTRICT OF COLUMBIA, GOVERNMENT OF	2201 SHANNON PL SE	WASHINGTON	DC	20020	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$315,000
2024	2023	DISTRICT OF COLUMBIA, GOVERNMENT OF	2201 SHANNON PL SE	WASHINGTON	DC	20020	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$0
2024	2022	DISTRICT OF COLUMBIA, GOVERNMENT OF	2201 SHANNON PL SE	WASHINGTON	DC	20020	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$0
2024	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	2201 SHANNON PL SE	WASHINGTON	DC	20020	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $315,000

Issue Date FY: 2023 ( Subtotal = $315,000 )
2023	2023	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	3	4/6/2023	NON-COMPETING CONTINUATION	$315,000
2023	2023	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	01	3	6/16/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	3	4/6/2023	NON-COMPETING CONTINUATION	$0
2023	2022	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	01	3	6/16/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	01	3	6/16/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	3	4/6/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $315,000

Issue Date FY: 2022 ( Subtotal = $315,000 )
2022	2022	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	2	4/20/2022	NON-COMPETING CONTINUATION	$315,000
2022	2022	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	01	2	6/30/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	01	2	6/30/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 North Capitol St Ne	Washington	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	02	1	2/4/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	2	4/20/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $315,000

Issue Date FY: 2021 ( Subtotal = $315,000 )
2021	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	01	1	7/1/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2021	2021	DISTRICT OF COLUMBIA, GOVERNMENT OF	899 NORTH CAPITOL ST NE	WASHINGTON	DC	20002	DISTRICT OF COLUMBIA	USA	Viral Hepatitis Prevention and Control	00	1	4/21/2021	NEW	$315,000
														Subtotal = $315,000

Grand Total All Awards = $1,260,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The application is to advance ending hepatitis epidemics by active surveillance, collaborations with clinical and community-based partners through testing, treatment, and focus populations.

Award Number: NU51PS005139

ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES

OPDIV: CDC

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer